|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/19 | |
| A61K 31/445 | |||
| A61P 25/28 | |||
| A61K 31/196 | |||
| A61K 45/06 |
| (11) | Number of the document | 2773337 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12778762.0 |
| Date of filing the European patent application | 2012-10-31 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/071631 |
| Date | 2012-10-31 |
| (87) | Number | WO 2013/064579 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 11306407 | 2011-10-31 | EP |
| (72) |
MOUTHON, Franck, FR
CHARVERIAT, Mathieu, FR
|
| (73) |
Commissariat ą l`Énergie Atomique et aux Énergies Alternatives,
Bātiment le Ponant D 25 rue Leblanc, 75015 Paris,
FR
|
| (54) | USE OF ANTI-CONNEXIN AGENTS FOR ENHANCING THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITORS |
| USE OF ANTI-CONNEXIN AGENTS FOR ENHANCING THE THERAPEUTIC EFFECT OF ACETYLCHOLINESTERASE INHIBITORS |